Three others groups investigated the B-cell deletion of Crebbp in combination with BCL2 overexpression to fit with the frequent co-occurrence of the two alterations in human FL and DLBCL (67–69). The gene discussed is CREBBP; the disease is diffuse large B-cell lymphoma.